Hypersensitivity to the active substance or to any of the excipients. Second and third trimesters of pregnancy. Do not co-administer IRBESARTAN with aliskiren-containing medicines in patients with diabetes or with moderate to severe renal impairment (glomerular filtration rate (GFR) <60 ml/min/l.73m2).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
